Literature DB >> 19294561

Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.

Aleksandra Holowiecka-Goral1, Jerzy Hołowiecki, Sebastian Giebel, Beata Stella-Holowiecka, Małgorzata Krawczyk-Kulis, Kinga Kos, Agata Lehmann-Kopydłowska, Marek Dudzinski, Magdalena Hałasz, Witold Preisner, Maria Cioch, Jarosław Piszcz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294561     DOI: 10.1080/10428190802702375

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  1 in total

1.  Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.

Authors:  Nicola Gökbuget; Christina-Maria Hartog; Renato Bassan; Heinz-Gerd Derigs; Herve Dombret; Richard Greil; Jesus-Maria Hernández-Rivas; Francoise Huguet; Tamara Intermesoli; Eric Jourdan; Christian Junghanss; Lothar Leimer; Maria-Jose Moreno; Albrecht Reichle; Josep Ribera; Matthias Schmid; Hubert Serve; Matthias Stelljes; Reingard Stuhlmann; Dieter Hoelzer
Journal:  Haematologica       Date:  2010-10-15       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.